Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Oregon

The Department of Consumer and Business Services (DCBS) Division of Financial Regulation announced the Prescription Drug Price Transparency (DPT) Program published PBM data results and analysis from its third year of collecting this data. This year, it received data for calendar year 2025. The payments PBMs received from manufacturers and reported to DPT for Oregon covered lives were more than $217 million. Most of these manufacturer payments – almost $210 million – were passed to insurers. The remainder of the payments were retained by the PBM or its affiliate ($6.4 million) or passed to enrollees ($875,000). Additionally, PBMs retained administrative fees of $25.8 million, four-fifths of the total ($20.1 million) from insurers and one-fifth ($5.7 million) from manufacturers. Refer to the published PBM data for additional details. For more information, contact the department at rx.prices@dcbs.oregon.gov.

Also in Oregon, the Board of Pharmacy adopted the following Temporary Rule and Vaccine Protocols during the September 18 special board meeting. While the Oregon Health Authority State of Oregon Statewide Standing Order is still valid, pharmacists should transition to using the Board’s Coronavirus 19 Protocol v. 09/2026 as their primary source of authority for prescribing/dispensing/administering COVID-19 vaccines.

September 22: Temporary Rule & Vaccine Protocols Noticed

Email all rulemaking related inquiries to pharmacy.rulemaking@bop.oregon.gov.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-10-02T15:18:29-04:00October 2, 2026|Oregon|

Oregon

The Board of Pharmacy posted the October 7-9 Board Meeting Agenda and meeting materials. Note the discussion of vaccine protocols on October 8 under agenda item “2. Rules Policy Discussion Items”. The Public may attend the board meeting in person or virtually during Open Session. Please see the meeting agenda for additional information. Also, additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-09-25T12:53:30-04:00September 25, 2026|Oregon|

Oregon

The Oregon Health Authority (OHA) issued a standing order that lets vaccine providers across the state begin giving updated COVID-19 vaccines. The statewide order signed last week by Dean Sidelinger, MD, MSEd, OHA’s health officer and state epidemiologist, matches similar steps taken in the other three West Coast Health Alliance (WHCA) states—Washington, California and Hawaii.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-09-11T13:29:38-04:00September 11, 2026|Oregon|

Oregon

The Oregon Health Authority released a statement that the West Coast Health Alliance continues to endorse the American Academy of Pediatrics-recommended child, adolescent immunization schedules.   

Also in Oregon, the Oregon Health Authority's Immunization Policy Advisory Team will meet on September 3. The Oregon Immunization Program works to reduce the incidence of vaccine-preventable disease in Oregon. Staff members identify and promote evidence-informed public health best practices to both the public and health care professionals throughout the state.  

What: Meeting of Oregon's Immunization Policy Advisory Team (IPAT) 

When: Thursday, Sept. 3, noon-2 p.m. 

Where: Virtually via Zoom – register HERE (required). Registrants will receive a confirmation email with additional information that they will need to join the meeting. 

Draft agenda items include: 

  • Public comment 
  • Respiratory season update 
  • RSV season patterns 
  • Standing Order update 
  • ALERT IIS Replacement Project update 
  • Future meeting settings 
  • Roundtable discussion 

Final agenda will be available at the meeting or via email request three days before the meeting date by contacting imm.info@odhsoha.oregon.gov. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-08-28T12:02:43-04:00August 28, 2026|Oregon|

Oregon

The August 12-13 Board of Pharmacy Meeting Agenda and meeting materials are now available. Please note the Board will discuss Divs 006/007/110/145 – Mobile Pharmacy (2026 HB 4131) (OAR 855- 006-0005, OAR 855-007-0030, OAR 855-007-0080, OAR 855-007- 0100, OAR 855-007-0110, OAR 855-110-0007, OAR 855-145-0001, OAR 855-145-0005, OAR 855-145-0010, OAR 855-145-0015, OAR 855- 145-0020, OAR 855-145-0025, OAR 855-145-0030; see attachment #B1. Please be advised that additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.   

Also in Oregon, the Prescription Drug Affordability Board (PDAB) published the "Oregon PDAB Quarterly" newsletter, Issue 15.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-07-30T18:06:44-04:00July 30, 2026|Oregon|

Oregon

The Board of Pharmacy posted the June 10-12 Board Meeting Agenda and meeting materials. Additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.  

Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted its draft agenda for the June 17 meeting. Check the PDAB website for updates prior to the meeting.  Register in advance. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-06-05T10:18:32-04:00June 5, 2026|Oregon|
Go to Top